Clinical Trial Update: Evaluate Effects and Safety of Pre-load Myfortic® in Transplant Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects and safety of Pre-load Myfortic in kidney transplant recipients has completed, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• MYFORTIC (MYCOPHENOLIC ACID)

Snippet

Sponsor: University of Cincinnati | Conditions: Kidney Transplant Recipients | Phase 4 | Status: COMPLETED | Results posted: 2016-04-11